Oxycodon G.L. (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon G.L., is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodon G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid that acts on the central nervous system to manage pain across several clinical settings. - Acute postoperative pain: provides strong analgesia during the immediate recovery period. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: used when long‑term opioid therapy is justified and other treatments have failed.

Adverse reactions to oxycodone may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: feeling of queasiness or urge to vomit. - Drowsiness: increased sleepiness or sedation. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: dependence or addiction. - Seizures: convulsive episodes. - Anaphylaxis: severe allergic reaction. - adrenal ​

Precautions: - Assess pain severity: confirm that opioid therapy is appropriate for the patient’s level of pain. - Evaluate renal and hepatic function: adjust use if impairment is present. - Review medication history: identify potential drug interactions before initiating therapy. - Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal symptoms. - Educate patients on safe use: advise on dosing, storage, and avoiding alcohol or sedatives. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Interactions: Major Interactions (Avoid): - CNS depressants: concurrent use with alcohol, benzodiazepines or other opioids can cause profound respiratory depression. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome. - CYP3D4 inhibitors: strong inhibitors such as ketoconazole can increase oxy‑cyste

Moderate